Telemedicine Practice Standards States Regulate: Consultation Requirements: Some states require live video or phone (not just messaging) Others allow asynchronous (message-based) consultations Documentation requirements vary Patient consent forms differ Prescribing Standards: What can be prescribed via telehealth Whether initial in-person visit required (rare for weight loss now) Documentation needed in medical record Follow-up requirements Examples of State Variations: More Restrictive States: May require video consultation (not just questionnaire) Additional documentation requirements More stringent informed consent Limitations on initial prescribing More Permissive States: Allow asynchronous consultations Streamlined documentation Fewer restrictions on telehealth prescribing Legitimate providers comply with each states specific requirements

Vomiting (coded as R11.1 for vomiting alone, plus Y42.3) occurs in 812% of patients and may necessitate temporary dose reduction or treatment interruption if severe
Exploratory protocols thus gain unique signaling benefit at the cost of more demanding monitoring complexity.
Common adverse effects include gastrointestinal symptoms, which affect the majority of patients to varying degrees: Nausea (20-44% of patients) usually most pronounced during dose escalation Diarrhea (20-30%) Constipation (15-24%) Vomiting (9-24%) Abdominal pain (6-10%) These symptoms typically diminish over time as physiological adaptation occurs
Liraglutide is the best studied in psychiatric populations and came off patent in December 2023, but the downside is that it requires daily injections
Understanding potential interactions between magnesium supplementation and GLP-1 medications, as well as other commonly prescribed drugs, is essential for safe and effective treatment